Comment on ‘Translating prognostic factors into clinical surveillance decisions in thin melanoma’
Clinical and Experimental Dermatology · 24.07.2026
DOI: 10.1093/ced/llag329 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical and Experimental Dermatology, online erschienen am 24.07.2026. Verfasst von Ercan Yılmaz und 2 weiteren Autor:innen. Beteiligte Einrichtung: Inonu University, Faculty of Medicine, Pediatric Allergy and Immunology Department, Malatya, Turkey. Die Arbeit nennt 4 Literaturangaben.
Abstract (Originalsprache)
Identifying prognostic factors for recurrence in thin melanoma is only the first step. Individualized surveillance should be guided by validated multivariable risk prediction models rather than isolated pathological features. Calibration and decision curve analysis are needed to demonstrate whether risk-adapted follow-up provides meaningful clinical benefit beyond statistical significance. We highlight the need for external validation and contemporary data before these findings are incorporated into routine melanoma surveillance guidelines.
Autor:innen und Institutionen
- Inonu University, Faculty of Medicine, Pediatric Allergy and Immunology Department, Malatya, Turkey.
ORCID-Profile: Ercan Yılmaz, Nezihe Koker Özer, Erdem Topal
Zitieren
APA
Yılmaz, E., Özer, N. K., & Topal, E. (2026). Comment on ‘Translating prognostic factors into clinical surveillance decisions in thin melanoma’. Clinical and Experimental Dermatology. https://doi.org/10.1093/ced/llag329
Vancouver
Yılmaz E, Özer NK, Topal E. Comment on ‘Translating prognostic factors into clinical surveillance decisions in thin melanoma’. Clinical and Experimental Dermatology. 2026. doi:10.1093/ced/llag329
BibTeX
@article{Ylmaz2026,
author = {Yılmaz, Ercan and Özer, Nezihe Koker and Topal, Erdem},
title = {Comment on ‘Translating prognostic factors into clinical surveillance decisions in thin melanoma’},
journal = {Clinical and Experimental Dermatology},
year = {2026},
doi = {10.1093/ced/llag329}
}
EUVIMED